All data are based on the daily closing price as of September 16, 2026
c
Center Laboratories
4123.TWO
0.97 USD
0.02
+2.11%
Overview
Last close
0.97 usd
Market cap
724.10M usd
52 week high
1.56 usd
52 week low
0.93 usd
Target price
N/A usd
Valuation
P/E
76.875
Forward P/E
2500
Price/Sales
13.8932
Price/Book Value
1.3242
Enterprise Value
722.63M usd
EV/Revenue
13.8666
EV/EBITDA
11.5387
Key financials
Revenue TTM
52.11M usd
Gross Profit TTM
22.55M usd
EBITDA TTM
7.00M usd
Earnings per Share
0.01 usd
Dividend
0.05 usd
Total assets
753.82M usd
Net debt
23.28M usd
About
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.